Hims & Hers shares drop 6% after FDA warning on semaglutide marketing claims
Hims & Hers Health Inc. (NYSE: HIMS) saw its stock fall 6% ...
In
Stock Market
Apple could reap big gains from on-device AI, says Bernstein analyst
Apple Inc. (NASDAQ: AAPL) may emerge as one of the largest beneficiaries ...
Natura offloads Avon operations in Central America for symbolic $1 in portfolio streamlining move
In another move to clean up its portfolio, Natura (NATU3) informed on ...
Cramer says Broadcom stock is only ‘getting cheaper’ over time: explained here
Broadcom Inc (NASDAQ: AVGO) has soared a whopping 140% since early April, ...
Top catalysts for Canada’s TSX Composite Index
Canadian stocks are firing on all cylinders this year, despite the headwinds ...
These 3 undervalued stocks are poised for a rally in the final quarter of 2025
Despite record highs in major US indexes, signs of economic deceleration are ...
Weekly wrap: markets rally, Charlie Kirk murder, iPhone 17 launch and PMs resign
The past week delivered a mix of market gains, corporate surprises, and ...
AstraZeneca pauses £200mn Cambridge investment amid UK pharma uncertainty
AstraZeneca has become the latest major drugmaker to scale back investment in ...
Top three ‘cash rich’ stocks that can weather any market downturn
With US equities hovering near record levels and economics indicators flashing warning ...
Evening digest: Trump honors Charlie Kirk, Figure’s blockbuster IPO, rising US Inflation
Thursday’s evening wrap covers major developments from politics, finance, and the economy. ...